相关实验视频

Updated: Jul 29, 2026

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

Ga-DOTA-Neratinib:一种用于乳腺癌成像的小分子PET标记剂

Shangjing Pang¹, Yuanzhuo Yan², Hongyin Ding¹

¹Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China; Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, China; Nuclear Medicine Institute of Southwest Medical University, Luzhou, China.

Bioorganic chemistry

|October 2, 2025

概括

一种新的PET成像剂68Ga-DOTA-Neratinib显示出对HER2阳性乳腺癌的前景. 这种新型的探测器准HER2受体,在临床前研究中证明了瘤吸收和保留的增强.

科学领域:

核医学就是核医学.
在瘤学瘤学.
放射化学放射化学是指辐射化学.

背景情况:

目前针对HER2 (人类表皮生长因子受体2) 的68Ga标记探针通常表现出瘤特异性吸收不足.
涅拉提尼布是一种强大的第二代泛HER氨酸激酶抑制剂,为开发改进的成像剂提供了机会.

研究的目的:

开发和评估一种新的正子发射断层扫描 (PET) 成像剂68Ga-DOTA-Neratinib,用于治疗HER2阳性乳腺癌.
评估探针的结合亲和力,稳定性和瘤特异性吸收 in vitro 和 in vivo.

主要方法:

68Ga-DOTA-Neratinib的合成和表征.
在实验室中使用HER2-阳性 (BT-474,SK-BR-3) 和HER2-阴性 (MCF-7) 细胞系进行细胞吸收测定.
在HER2阳性瘤携带的小鼠模型中进行体内微PET/CT成像.

主要成果:

探测器表现出高的放射性化学产量和出色的体外和体外稳定性.
与HER2-阴性细胞相比,在HER2-阳性细胞系中观察到68Ga-DOTA-Neratinib的特定和显著的积累.
微PET/CT成像显示,HER2阳性瘤中瘤吸收增强和瘤内保留延长,并注意到一些背景血液活性.

结论:

68Ga-DOTA-Neratinib对HER2受体具有很高的亲和力以及有利的药理动力学特性.
开发的PET探针显示了对HER2阳性乳腺癌的非侵入性成像的潜力.
需要进一步的研究,以探索其在HER2向癌症诊断中的临床实用性.

关键词:

(68) 标有Ga的标签尼拉丁尼布 (Neratinib) 是一种有毒的药物.在这里,PET是PET.无线电联盟的成员.放射学成像成像放射学成像成像追踪器是一种追踪器.

更多相关视频

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Automated Preparation of [⁶⁸Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET